Statins (HMG-CoA reductase inhibitors), cholesterol and stroke

被引：1

作者：

Marta-Moreno, J ^{[1
]}

Echeandia, C ^{[1
]}

Oliveros-Cid, A ^{[1
]}

Figuerola, A ^{[1
]}

Mola, S ^{[1
]}

机构：

[1] Hosp Miguel Servet, Serv Neurol, E-50009 Zaragoza, Spain

来源：

REVISTA DE NEUROLOGIA | 1998年 / 27卷 / 159期

关键词：

cerebral ischemia; cholesterol; HMG-CoA reductase; stroke;

D O I：

10.33588/rn.27159.98262

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The HMG-CoA reductase inhibitors (known as statins) have been shown to reduce morbi-mortality of vascular origin, including transitory ischemic accidents and cerebral infarcts, in a large group of patients. The implications, both clinical and of costs, oblige us to consider analysis of the existing evidence and the answers to a number of questions arising in a field which has not yet received much attention from neurologists.

引用

页码：827 / 830

页数：4

共 50 条

[31] Syntheses of some α-cyclic tripeptides as potential inhibitors for HMG-CoA Reductase
Subrata Chakraborty
Shih-Hung Lin
David Shiuan
Dar-Fu Tai
Amino Acids, 2015, 47 : 1495 - 1505
[32] Peptide inhibitors of human HMG-CoA reductase as potential hypocholesterolemia agents
Lin, Shih-Hung
Chang, Ding-Kwo
Chou, Mei-Ju
Huang, Kao-Jean
Shiuan, David
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (01) : 104 - 109
[33] Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors
Terzoli, L
Mircoli, L
Raco, R
Ferrari, AU
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (03) : 310 - 315
[34] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
Pak, Valeriy V.
Kwon, Dae Yong
Khojimatov, Olim K.
Pak, Aleksandr, V
Sagdullaev, Shomansur Sh
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (03) : 1923 - 1931
[35] Molecular docking and ADMET analysis of synthetic statins for HMG-CoA reductase inhibition activity
Toppo, Aditya L.
Yadav, Manisha
Dhagat, Swasti
Ayothiraman, Seenivasan
Eswari, Jujjavarapu Satya
INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2021, 58 (02) : 127 - 134
[36] HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons
Chao, Chun
Xu, Lanfang
Abrams, Donald I.
Towner, William J.
Horberg, Michael A.
Leyden, Wendy A.
Silverberg, Michael J.
AIDS, 2011, 25 (14) : 1771 - 1777
[37] Pitavastatin: A New HMG-CoA Reductase Inhibitor
Wensel, Terri M.
Waldrop, Bruce A.
Wensel, Brian
ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 507 - 514
[38] HMG-CoA reductase inhibitorsMyalgia: case report
Reactions Weekly, 2010, 1314 (1) : 22 - 22
[39] Regulation of HMG-CoA reductase in mammals and yeast
Burg, John S.
Espenshade, Peter J.
PROGRESS IN LIPID RESEARCH, 2011, 50 (04) : 403 - 410
[40] Monitoring the cellular effects of HMG-CoA reductase inhibitors in vitro and ex vivo
Cicha, I
Schneiderhan-Marra, N
Yilmaz, A
Garlichs, CD
Goppelt-Struebe, M
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) : 2046 - 2050

← 1 2 3 4 5 →